Meeting Details
The Extra-Ordinary General Meeting of Kilitch Drugs (India) Limited was held on Monday, 16 November, 2026 at 9:00 am through Video Conferencing/Other Audio Visual Means (VC/OAVM). The meeting commenced at 9:00 am and concluded at 9:50 am, lasting 50 minutes.
Attendance
Total members attended: 56 (Promoter and Promoter Group: 3, Public: 53)
Key participants included:
- Mr. Mukund Mehta, Managing Director (Chairman)
- Mrs. Mira Mehta, Managing Director
- Mr. Bhavin Mehta, Wholetime Director
- Prof. Vasudev Krishna Murti, Independent Director
- Mr. Dipen Jain, Independent Director
- Mr. Milind Kishor Madhani, Independent Director (additional)
- Mr. Gautam Rajan, Independent Director (additional)
- Mr. Sunil Jain, Chief Financial Officer
- Ms. Pushpa Nyoupane, Company Secretary
- Mr. Deep Shukla, Proprietor of Deep Shukla & Associates (Secretarial Auditors and Scrutinizer)
- Mr. Arvind Kumar, Proprietor of Arvind Kumar and Co. (Cost Auditors)
Business Transacted
The following resolutions were considered and approved at the meeting:
Resolution No. 1: Approval to sell the entire shareholding held by the company in its material subsidiary.
Resolution No. 2: Approval to convert the existing debt extended by the company including service cost into equity shares of its material subsidiary.
Resolution No. 3: Approval of appointment of Dr. Milind Kishor Madhani (DIN: 02378529) as a non-executive Independent Director of the company for a period of five consecutive years.
Resolution No. 4: Approval of appointment of Mr. Gautam Rajan (DIN: 00060730) as a non-executive independent director of the company for a period of five consecutive years.
Meeting Proceedings
Mr. Mukund Mehta, Managing Director, chaired the meeting. The meeting had requisite quorum present. Ms. Pushpa Nyoupane, Company Secretary, welcomed attendees and provided general instructions regarding participation through video conferencing and remote e-voting. All panelists were introduced to shareholders.
Mr. Mukund Mehta addressed members on the company's performance and business prospects. Speaker shareholders were allowed to ask queries, which were responded to during the meeting.
Voting and Results
The e-voting facility was made available to members for 15 minutes post conclusion of the meeting. The details of voting results along with the Scrutinizer's Report will be disseminated to Stock Exchanges separately and placed on the Company's website in due course.
Financial Impact
Financial impact of the subsidiary sale and debt conversion not quantified in the disclosure.